Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Immunology
Импакт фактор: 1.352 5-летний Импакт фактор: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472

Том 39, 2019 Том 38, 2018 Том 37, 2017 Том 36, 2016 Том 35, 2015 Том 34, 2014 Том 33, 2013 Том 32, 2012 Том 31, 2011 Том 30, 2010 Том 29, 2009 Том 28, 2008 Том 27, 2007 Том 26, 2006 Том 25, 2005 Том 24, 2004 Том 23, 2003 Том 22, 2002 Том 21, 2001 Том 20, 2000 Том 19, 1999 Том 18, 1998 Том 17, 1997 Том 16, 1996 Том 15, 1995 Том 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.2017018916
pages 315-327

Acquired T-Cell Immunodeficiency in Thymoma Patients

Petros Christopoulos
Department of Thoracic Oncology, Thoraxklinik at the Heidelberg University Medical Center, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Rontgenstr. 1, 69126 Heidelberg, Germany
Paul Fisch
Department of Pathology, University Medical Center Freiburg, Breisacher Str. 115a, 79106 Freiburg, Germany

Краткое описание

Acquired T-cell immunodeficiency can occur in thymoma patients with or without hypogammaglobulinemia (Good's syndrome), but it has received little attention to date. It appears predominantly associated with lymphocyte-rich (i.e., cortical or mixed) thymomas and frequently coexists with autoimmune manifestations. The main abnormalities are an increase in circulating naive T cells, cutaneous T-cell anergy, TCR hyporesponsiveness in vitro as well as a numerical and functional impairment of regulatory T cells. All of these probably result from an abnormal T-cell maturation in the neoplastic thymic microenvironment. A better understanding of thymoma-related acquired T-cell immunodeficiency will be important for immunotherapy of this orphan disease as well as for the prevention and treatment of opportunistic infections, autoimmune complications and secondary malignancies that contribute to the morbidity and mortality of thymoma patients.

Articles with similar content:

Pathogenesis of Multiple Organ Failure in Sepsis
Critical Reviews™ in Immunology, Vol.35, 2015, issue 4
Alexander Zarbock, Jan Rossaint
p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Jacques E. Nör, Christie Rodriguez-Ramirez
Tumor Antigen Presentation by Dendritic Cells
Critical Reviews™ in Immunology, Vol.30, 2010, issue 4
Nina Dickgreber, Ian F. Hermans, Troels R. Petersen
Gaucher Disease and Myeloma
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 3
Derralynn A. Hughes, Robert Ayto
Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway
Forum on Immunopathological Diseases and Therapeutics, Vol.6, 2015, issue 1-2
Haydn T Kissick, Eunseon Ahn, Junghwa Lee, Rafi Ahmed